
SMFR
Healthcare · Healthcare Providers & Services · $120.1M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2022
EPS trend, 90 days to now · +20.0% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 13, 2023 | Before the open | -0.16 | -0.90 | -462.5% |
| Nov 14, 2022 | Before the open | -0.21 | -0.20 | +4.8% |
| Aug 15, 2022 | After the close | -0.21 | -0.22 | -4.8% |
| May 12, 2022 | After the close | -0.31 | -0.27 | +12.9% |
| Mar 14, 2022 | After the close | -0.26 | -0.17 | +34.6% |
| Nov 15, 2021 | After the close | -0.19 | 0.15 | +178.9% |
| Jul 21, 2021 | After the close | — | -0.21 | — |
| May 24, 2021 | Before the open | — | -1.06 | — |
| Mar 30, 2021 | After the close | — | -0.00 | — |
| Nov 16, 2020 | Time not confirmed | — | 0.00 | — |
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights,…